Please check your internet connection and try again.
# Clotrimazole Drop
## Overview
Clotrimazole is a topical synthetic imidazole antifungal agent. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, leading to increased membrane permeability and cell death.
## Primary Indications
* Onychomycosis (fungal infection of the nails)
## Adult Dosing
Apply a thin layer to the affected nails once or twice daily, as directed by the prescriber. Duration of treatment is typically prolonged and depends on the extent of infection and response.
## Pediatric Dosing
Safety and efficacy in pediatric patients for onychomycosis have not been well-established. Use is generally not recommended unless specifically indicated and supervised by a healthcare professional.
## Dose Adjustments
No specific dose adjustments are necessary for renal or hepatic impairment.
## Contraindications
* Hypersensitivity to clotrimazole or any component of the formulation.
## Adverse Effects
* Application site reactions: burning, itching, stinging, redness, peeling, dryness.
* Nail discoloration.
* Hypersensitivity reactions (rare).
## Key Drug Interactions
Topical clotrimazole is not expected to have significant systemic drug interactions due to minimal absorption.
## Monitoring
* Clinical signs and symptoms of fungal infection.
* Resolution of nail discoloration and thickening.
* Adverse effects.
## Clinical Pearls
* Complete treatment course is crucial for efficacy, as onychomycosis is difficult to treat and requires prolonged therapy (often 6-12 months or longer).
* Ensure nails are clean and dry before application.
* Advise patients to avoid occlusive dressings unless specifically instructed.
* Consider adjunctive therapies like nail debridement for better penetration and outcomes.
***
*Disclaimer: This information is intended for a clinical pharmacist and does not replace a thorough review of the current prescribing information, institutional protocols, and individual patient assessment. Always verify current drug information before making clinical decisions.*